These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5046733)

  • 1. Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells.
    Shorter RG; Huizenga KA; Spencer RJ; Guy SK
    Am J Dig Dis; 1972 Aug; 17(8):689-96. PubMed ID: 5046733
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphotoxin in nonspecific inflammatory bowel disease lymphocytes.
    Shorter RG; Huizenga KA; Spencer RJ; Weedon D
    Am J Dig Dis; 1973 Feb; 18(2):79-83. PubMed ID: 4683459
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells.
    Stobo JD; Tomasi TB; Huizenga KA; Spencer RJ; Shorter RG
    Gastroenterology; 1976 Feb; 70(2):171-6. PubMed ID: 1082423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine.
    Campbell AC; Skinner JM; Hersey P; Roberts-Thomson P; MacLennan IC; Truelove SC
    Clin Exp Immunol; 1974 Apr; 16(4):521-33. PubMed ID: 4468852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gastroenterology; 1973 Jul; 65(1):1-7. PubMed ID: 4720822
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of in vitro cytotoxicity of lymphocytes from patients with chronic ulcerative colitis or granulomatous colitis for allogenic colonic epithelial cells.
    Shorter RG; Cardoza MR; ReMine SG; Spencer RJ; Huizenga KA
    Gastroenterology; 1970 May; 58(5):692-8. PubMed ID: 4910397
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological aspects of inflammatory bowel disease.
    Whorwell PJ; Wright R
    Clin Gastroenterol; 1976 May; 5(2):303-21. PubMed ID: 1037288
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effects of colectomy.
    Shorter RG; Cardoza M; Spencer RJ; Huizenga KA
    Gastroenterology; 1969 Feb; 56(2):304-9. PubMed ID: 5764597
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
    Korsmeyer S; Strickland RG; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating immune complexes in inflammatory bowel disease.
    Jewell DP; MacLennan IC
    Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].
    Hibi T; Ogata H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):499-504. PubMed ID: 15052810
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.
    MacDermott RP; Franklin GO; Jenkins KM; Kodner IJ; Nash GS; Weinrieb IJ
    Gastroenterology; 1980 Jan; 78(1):47-56. PubMed ID: 7188608
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.
    Gibson PR; van de Pol E; Pullman W; Doe WF
    Gut; 1988 Aug; 29(8):1076-84. PubMed ID: 3261705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the spontaneous lymphocyte toxicity in colonic carcinoma].
    Eder E; Mühe E; Kratzsch G; Warnatz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1215-7. PubMed ID: 306168
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.
    Strickland RG; Friedler EM; Henderson CA; Wilson ID; Williams RD
    Clin Exp Immunol; 1975 Sep; 21(3):384-93. PubMed ID: 1081934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunology of inflammatory bowel disease.
    Bartnik W; Shorter RG
    Mater Med Pol; 1981; 13(2):77-84. PubMed ID: 7047915
    [No Abstract]   [Full Text] [Related]  

  • 18. The in-vitro action of lymphocytes on autologous colon epithelial cells in ulcerative colitis.
    Hunt PS; Trotter S
    Aust N Z J Surg; 1975 May; 45(2):214-9. PubMed ID: 1059409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies of in vitro cytotoxicity of lymphocytes for colonic epithelial cells.
    Shorter RG; Cardoza M; Huizenga KA; ReMine SG; Spencer RJ
    Gastroenterology; 1969 Jul; 57(1):30-5. PubMed ID: 4892359
    [No Abstract]   [Full Text] [Related]  

  • 20. Histocompatibility antigens in patients with inflammatory-bowel disease.
    Asquith P; Mackintosh P; Stokes PL; Holmes GK; Cooke WT
    Lancet; 1974 Jan; 1(7848):113-5. PubMed ID: 4130311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.